Nociceptive behaviour induced by dental application of irritants to rat incisors: a new model for tooth inflammatory pain.
Animal models simulating acute human pulpitis are still lacking. The rat incisors present a particular situation where most of their innervation is considered to be unmyelinated and concentrated mainly in the tooth pulp. This study reports on a new model for dental pain induced by inflammatory agents applied to the tooth pulps of incisors. In different groups of rats, artificial crowns were fixed on the lower incisors, after cutting 1-2mm of their distal extremities. A volume of 7-10 microl of solutions of saline, capsaicin (1-10mg/ml) or formalin (2.5% or 5%) was injected in the crown cavity, and the nociceptive behaviour was quantitated following a devised scoring method of four scales. Intradental application of capsaicin produced nociceptive scores in the form of one plateau for 1-2h depending on the concentration used. Similar results were obtained with intradental application of formalin 2.5%. The one plateau of nociceptive scores obtained with formalin contrasts with the biphasic aspect of nociceptive behaviour described with the intradermal formalin test. This discrepancy could be attributed to a difference in the types of afferent fibres involved in each situation. Pretreatment with morphine (2 mg/kg) attenuated, in a naloxone-reversible manner, the nociceptive behaviour observed following intradental application of capsaicin. Pretreatment with meloxicam (a cyclo-oxygenase-2 inhibitor) exerted a less pronounced attenuation of the nociceptive scores when compared with morphine. These results provide evidence for the validity of the described model for the simulation of tooth pulp inflammatory pain in awake animals.
Chidiac
José-Johann
JJ
Department of Prosthodontics, School of Dentistry, Lebanese University, Beirut, Lebanon.
Rifai
Khaldoun
K
Hawwa
Nadim N
NN
Massaad
Cynthia A
CA
Jurjus
Abdo R
AR
Jabbur
Suhayl J
SJ
Saadé
Nayef E
NE
D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D002211:Capsaicin / Q000494:pharmacology; D003442:Crowns; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D003786:Dental Pulp Cavity / Q000187:drug effects* / Q000294:innervation* / Q000503:physiopathology; D004195:Disease Models, Animal; D004347:Drug Interactions / Q000502:physiology; D005260:Female; D005557:Formaldehyde / Q000494:pharmacology; D005881:Gingiva / Q000187:drug effects / Q000294:innervation / Q000503:physiopathology; D007249:Inflammation / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D000077239:Meloxicam; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009412:Nerve Fibers / Q000187:drug effects* / Q000648:ultrastructure; D009619:Nociceptors / Q000166:cytology / Q000187:drug effects*; D010147:Pain Measurement / Q000187:drug effects / Q000379:methods*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013843:Thiazines / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology; D014098:Toothache / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology
D000701:Analgesics, Opioid; D016861:Cyclooxygenase Inhibitors; D009292:Narcotic Antagonists; D013843:Thiazines; D013844:Thiazoles; D005557:Formaldehyde; D009270:Naloxone; D009020:Morphine; D002211:Capsaicin; D000077239:Meloxicam